Works matching IS 15268209 AND DT 2014 AND VI 14 AND IP 3


Results: 14
    1
    2
    3

    A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer.

    Published in:
    Clinical Breast Cancer, 2014, v. 14, n. 3, p. 154, doi. 10.1016/j.clbc.2013.12.012
    By:
    • Jhaveri, Komal;
    • Chandarlapaty, Sarat;
    • Lake, Diana;
    • Gilewski, Teresa;
    • Robson, Mark;
    • Goldfarb, Shari;
    • Drullinsky, Pamela;
    • Sugarman, Steven;
    • Leiblich, Carolyn Wasserheit;
    • Fasano, Julie;
    • Moynahan, Mary Ellen;
    • D'Andrea, Gabriella;
    • Lim, Kristina;
    • Reddington, Laura;
    • Haque, Sofia;
    • Patil, Sujata;
    • Bauman, Lynne;
    • Vukovic, Vojo;
    • El-Hariry, Iman;
    • Hudis, Clifford
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14